2.Exploring on Source of Fu-Zheng Therapy as Major Traditional Chinese Medicine Cancer Treatment
Jialin YAO ; Qing WANG ; Ling XU
World Science and Technology-Modernization of Traditional Chinese Medicine 2013;(5):1089-1095
Fu-Zheng Pei-Ben therapy, as a major therapeutic principle, has become the main guiding thought of cancer therapy currently. Through the traditional Chinese medicine (TCM) history, Fu-Zheng Pei-Ben thera-py is one of the most important therapies . As early as the Spring and Autumn Period , the importance of vital qi has been recorded in the Huang-Di Nei-Jing. After that, TCM doctors have enriched the connotation and extension of the Fu-Zhe ng therapy . Until modern times , Professor Liu Jiaxiang applied Fu-Zhe ng therapy to the treatment of cancer . This paper explained the sources of Fu-Zhe ng cancer therapy through the analy-sis of its history in order to provide a reference to deepen the theoretical studies in the diagnosis and treat-ment of cancer in the future .
3.Clinical study on the treatment for chronic hepatitis B with ?-2b interferon combined with matrine
Cheng XU ; Qing HE ; Song WANG
Chinese Journal of Practical Internal Medicine 2002;0(08):-
0.05).The HBeAg-turned-to-negative rate was 57% in the treated group and 38.8% in the control group.The HBVDNA-turned-to-negative rate was 59.3% in the treated group and 42.4% in the control group (P
4.The effect analysis of supplementary immunization activities of hepatitis B vaccine in Chongqing city from 2004 to 2012
Shanshan KUANG ; Qing WANG ; Jiawei XU
Chongqing Medicine 2014;(20):2637-2638,2671
Objective To evaluate the work effect after supplementary immunization activities (SIAs) of Hepatitis B vaccine , thus to find the focal point in future hepatitis B prevention .Methods useing statistical method to analysis the data of investigation from 2004 to 2012 of hepatitis B vaccination rate ,the data of selective SIAs of hepatitis B vaccine and the incidence of hepatitis B . Results With the supporting of GAVI project ,the whole course vaccination rate and the timely first dose rate of hepatitis B were obviously increased(P<0 .01) ,supplementary immunization rate of hepatitis B was increased year by year and the incidence of hep-atitis B among 0-14 years old children decreased at 78 .42/100 ,000 .Conclusion The vaccination rate of hepatitis B shows a high and stable trend in Chongqing ,but we need to form a long term mechanism without project supporting to push forward hepatitis B prevention for the newborn .And on the base of doing good jobs in hepatitis B vaccination for the newborn ,we should also expand the hepatitis b vaccination priority to people over the age of 14 .
5.Study on the epidemiological characteristics of rubella from 2008 to 2013 in Chongqing
Shanshan KUANG ; Jiawei XU ; Qing WANG
Chongqing Medicine 2015;(16):2245-2246,2249
Objective To analyze the epidemiological characteristics of rubella since 2008 ,while the vaccine first used in Chongqing .Methods Descriptive epidemiological study was applied to analyze the cases on rubella from 2008 to 2013 ,and the Excel was used for data analysis .Results From 2008 to 2010 ,the rubella incidence rate reported in Chongqing decreased from 18 .97 per 100 000 to 2 .07 per 100 000 ,but it gave a rebounding trend in 2011 to 2012 .The rubella cases mostly affected children of 6 -14 years old and the epidemic peak was from April to June .Although ,the vaccination rate of rubella increased year by year from 2008 to 2013 ,even in 2012 it reached up to 90% ,but the vaccination coverage was low in primary and middle schools .100 epidemic out‐breaks happened ,91% of which happened in primary and middle schools ,accounting for 18 .74% of all reported cases .Conclusion Students in primary and middle school were easily infected with rubella virus ,the vaccination work should be strengthened for fur‐ther control the rubella infection .Secondary immune of Rubella vaccine of 6 or 7 years old children will contribute to control the outbreak of rubella among school‐age children ,and the rubella vaccine should expand its immunization objects .
6.Study on the risk factors of HBV infection among spouses of HBsAg carriers
Qing WANG ; Jiawei XU ; Ning YAO
Chongqing Medicine 2014;(21):2767-2769
Objective To investigate the risks of HBV infection among the spouses of HBV surface antigen (HBsAg)carriers and to find out effective control strategies on hepatitis B control and prevention .Methods To use case-control study(1∶2) including spouses of HBsAg carriers aged 18 -59 years-old from the nationwide sero-epidemiological survey for Hepatitis B in Chonqing province in 2005 ,and the spouses of the healthy(HBsAg negative persons)as the control groups ,adopt euzymelinked immunosor-bent assay(ELISA) to carry out the sero-epidemiological testing (HBsAg ,anti-HBc ,anti-HBs) for Hepatitis B .Results The posi-tive rate of HBsAgamong the spouses of HBsAg carriers (14 .8% ) was higher than the rate of spouse among the healthy (7 .5% ) , with difference statistically significant (P<0 .01) ,the positive rate of HBsAg in female spouse was uptrend as the marriage age grown ,multiple factor analysis found that the risks of HBV infection among the spouses were their spouse with HBsAg and without condom when the sexual behavior .Conclusion The spouses of HBsAg carriers have high risks of HBV .Premarital examinations , safety sexual behaviors with condom ,timely hepatitis B vaccination etc .are helpful for the spouses of HBsAg carriers free of hepati-tis B virus ,especially female spouses should insist on using condom when the sexual behavior because of them easier to be infected by the hepatitis B virus .
7.Effects of Chinese herbal medicine Feiyanning decoction on expressions of nucleosome conformation-regulating factors H3-K56, Rtt109, Asf1 and E2F1 in Lewis-bearing mice.
Juyong WANG ; Qing WANG ; Ling XU ; Zhenye XU
Journal of Integrative Medicine 2012;10(4):448-53
Malignant tumor cells were found with an abnormal cell cycle. Previous in vivo experiment had confirmed the Feiyanning's intervention effect on checkpoint signaling of G1/S in the cell cycle. This study was to further observe the expressions of nucleosome conformation-regulating factors intervened by Feiyanning decoction in S phase.
8.Comparison of routine test kits of creatinine in human serum with reversed-phase high-pressure liquid chromatographic assay
Jing XU ; Qing-Tao WANG ; Guo-Bin XU ;
Chinese Journal of Laboratory Medicine 2000;0(06):-
98.95%.The results of certified reference materials were consistent with the target value,and average deviation was -0.31%~1.35%.HPLC was served as the independent variable.When ereatinine was 200 ?mol/L,Bias of Beckman LX20 system,Vitros dry chemistry system and enzymatic method were -10%~13%,-13%~14% and -20%~10%,respectively.Bias of enzymatic method results was mostly negative,when creatinine was
9.One-stage urethroplasty by using perineal and preputial island flaps for hypospadias
Qing ZHANG ; Qian WANG ; Wanhua XU ; Bing XU
Chinese Journal of Primary Medicine and Pharmacy 2006;0(01):-
Objective To research the operation method for hypospadias by one-stage urethroplasty.Methods According to the length of urethra defect,18 cases were operated by using one-stage urethroplasty with perineal and preputial island flaps.Results 16 cases were successful in all patients(88.9%),except one case of urethrostenosis and urethral fistula respective.The case of urethrostenosis recovered by dilation of urethra after 5 months and the patient of urethral fistula was successfully repaired by operation after 8 months.All patients were followed up for 6~26 months with satisfactory penis and micturition.Conclusion The technique of one-stage urethroplasty by using perineal and preputial island flaps is the one of best choices for hypospadias.
10.Expression of soluble urakinase-type plasminogen activator receptor and its role on the prognosis ofmultiple myeloma
Jie SHEN ; Juan WANG ; Ruihuan WANG ; Qing WANG ; Weixing XU
Journal of Leukemia & Lymphoma 2011;20(11):663-665
ObjectiveTo investigate the serum soluble urokinase-type plasminogen activator (suPAR)in patients with multiple myeloma,its relationship with the 2-year survival rate and its clinical significance in predicting the disease prognosis.MethodsEnzyme-linked immunosorbent assay was applied to determine the levels of suPAR of 40 initial diagnosed patients with MM and 30 healthy persons as healthy control group.The patients were divided into three groups:effective (13 cases),remission (19 cases) and invalid (8 cases).ResultsUsually there was suPAR expression [(233.47±83.22) pg/ml] in serum of the healthy adults.There was no statistical difference of the suPAR expression in effective group or remission group before treated [(257.60±32.47) pg/ml,(331.00±99.80) pg/ml] compated with healthy group (t =2.04,t =1.83,P > 0.05),and that in the invalid group,serum levels of suPAR [(562.20±291.0) pg/ml] was statistically significant with that of the effective group and that of the healthy control group (t =3.92,t =1.93,P < 0.05).Through monitoring 17 patients,the suPAR of patients before treatment [(437.65±131.43) pg/ml] was statistically significant with that of healthy control group (P <0.01) and effective group after treatment [(298.76±108.59) pg/ml] (P <0.01).Serum suPAR of more than 2-year-survival patients [(333.02±85.37) pg/nl] during initial diagnosis was not statistically difference with that of the healthy control group (t =1.81,P > 0.05).Serum suPAR of less than 2-year-survival patients [(646.01±103.97) pg/ml] was statistically different with that of healthy control group (t =3.84,P <0.01) and that of more than 2-year-survival patient group (t =3.50,P <0.01).ConclusionThe suPAR value was correlated to the stability of multiple myeloma,and can be used for disease prognosis and estimation of survival time.And the high expression of suPAR was related to the adverse prognosis.